Genetics Flashcards
3 categories of genetic DOs
mutation in a single gene with large effects (Mendelian DOs)
chromosomal DOs
Complex multigenic DOs
Mendelian DOs
rare, high penetrance
Sickle cell anemia: strong selective forces (malaria) maintain mutation in population
Chromosomal DOs
structural or numerical alterations in autosomes and sex chromosomes
uncommon
high penetrance
Complex multigenic DOs
more common
Low penetrance
environment and gene interactions (aka polymorphisms)
no single gene necessary or sufficient to produce disease
Examples of complex multigenic DOs
atherosclerosis, diabetes, hypertension, autoimmune diseases, ht and wt
Mutation
permanent change in the DNA
Germ cell mutations give rise to
inherited disease
Somatic cells give rise to
cancer and some congenital malformations
Point mutations within coding sequence
Missense: alter meaning of sequence of encoded protein (sickle cell–>Glu to Val)
Nonsense: stop codon
Mutations in non-coding sequences
promotor or enhancer sequences
defective splicing of intervening sequences
no translation
transcription factors
3 most common transcription factors
MYC, JUN, p53
Deletions and insertions
if multiple of 3, reading frame is intact–>abnormal protein
Frameshift mutation
deletion or insertion not in a multiple of 3–>altering of reading frame
Trinucleotide repeat
amplification of a sequence of 3 nucleotides
almost all contain guanine and cytosine
Anticipation
a genetic disorder is passed on to the next generation, the symptoms become apparent at an earlier age with each generation
increase in severity of symptoms
Huntington’s disease, myotonic dystrophy
Mendelian disorders
every individual is a carrier of 5-8 deleterious genes, most are recessive and no serious phenotypic effects
Codominance
both alleles contribute to phenotype
Pleiotropism
single mutant gene–>many end effects
Genetic heterogeneity
mutations at several loci may produce the same trait
Autosomal dominant (AD) DOs
manifest in the heterozygous state (only one gene affected) so 1 parent is usually affected
New mutations in AD DOs
seem to occur in germ cells of relatively older fathers
if disease decreases reproductive fitness, then most cases would have to be from new mutations
Incomplete penetrance
positive mutation but normal phenotype
Variable expressivity
all positive traits, but expressed differently
Example of variable expressivity
Neurofibromatosis type 1: can have or not have cafe-au-lait spots, skeletal deformities, and/or neurofibromas
decreased product, dysfunctional or inactive protein produced in AD DOs
Loss of function mutations: familial hypercholesterolemia
Gain of function mutations: huntingtin protein toxic to neurons
2 main patterns of disease with AD
regulation of complex metabolic pathways, subject to feedback inhibition
key structural proteins
LDL receptor in familial hypercholesterolemia
50% reduction in receptor–>secondary increase in cholesterol–>atherosclerosis
Key structural proteins affected in AD DOs
collagen and cytoskeletal elements of the RBC membrane (e.g. Spectrin)
Osteogenesis imperfecta
mutant allele can interfere with assembly of functionally normal multimer
AD DO
Age of onset for AD DOs
delayed; symptoms appear in adulthood (30s-50s)
Pedigree for AD
every generation
equally male and female overall
50/50 chance of getting it every generation
Examples of AD disorders
Huntington's disease neurofibromatosis Marfan syndrome Ehlers-Danlos syndrome Osteogenesis imperfecta Familial hypercholesterolemia
Examples of AR disorders
cystic fibrosis phenylketonuria lysosomal storage diseases glycogen storage diseases Sickle cell anemia
Pedigree in AR disorders
Skips generations
affects males and females equally
both males and females can be carriers
AR DOs
largest
both alleles are mutated
3 features of AD DOs
trait usually NOT affect parents
siblings have 1/4 chance of having trait
if mutation is of low frequency in population, strong likelihood proband product of consanguineous marriage
Differentiation between AR and AD
similar trait/phenotype in AR
complete penetrance common
onset EARLY IN LIFE
new mutations rarely detected clinically
many mutations involve enzymes–>inborn errors of metabolism
decreased normal enzyme of defective enzyme
Cystic fibrosis bacterial pathogens
Staphylococcus aureaus, Haemophilus influenzae, and Pseudomonas aeruginosa
Primary defect in cystic fibrosis
CFTR gene on chromosome 7q31.2
epithelial chloride channel protein
What does cystic fibrosis affect (generally)?
fluid secretion in exocrine glands and in the epithelial lining of the respiratory, GI, and reproductive tracts
abnormal viscous secretions that obstruct organ passages
Main consequences of CF
chronic lung disease (recurrent infections), pancreatic insufficiency, steatorrhea, malnutrition, hepatic cirrhosis, intestinal obstruction, and male infertility
When does CF appear?
at any point in life from before birth to much later into childhood or adolescence
CF pancreas
slightly hyperemic, granular, exaggerated lobulation, rounded edges
cysts, chronic pancreatitis
Bronchiectasis
airway dilation and scarring of bronchus due to persistent or severe infections
signs/symptoms: cough, purulent sputum, fever
Emphysema
airspace enlargement; wall destruction of acinus due to tobacco smoke
signs/symptoms: dyspnea
SI of CF pts
meconium ileus: unable to pass a stool within the first 48 hours of birth due to distended SI
What is the most common lethal genetic disease that affects Caucasian populations?
CF; 1 in 2500 live births
Who has a higher incidence of respiratory and pancreatic disease as compared with the general population?
Heterozygous carriers of CF
Genes other than CFTR modify the frequency and severity of certain organ-specific manifestations such as what?
pulmonary manifestations and meconium ileus
Male urogenital abnormalities and CF
obstructive azoospermia
How to test for CF?
sweat chloride test–>infant will taste salty to the mother
Phenylketonuria (PKU)
Scandinavian descent; NOT AA or Jewish
AR
phenylalanine hydroxylase (PAH) deficiency–>too much phenylalanine
What does PAH convert phenylalanine to?
tyrosine
tyrosine is a precursor for melanin
When does PKU present?
6 months
Signs and symptoms of PKU
severe MR, hypopigmentation of hair and skin, eczema
musty/mousy odor of urine
Treatment of PKU
dietary restrictions
Deficiency of what other enzyme besides PAH can give rise to PKU?
DHPR
X-linked Recessive DOs
Duchenne muscular dystrophy
glucose-6-phosphate dehydrogenase deficiency
Fragile X syndrome
Affects on males of X-linked recessive DOs
infertility, hence no Y-linked inheritance
What is the affect on women with X-linked recessive DOs?
all daughters of affected males are carriers
heterozygous female not express full phenotypic change because of normal paired allel
Pedigree for X-linked recessive DOs
all males; skipping generations
Mitochondrial inheritance
all from mom
affected males do not pass it on
all positive females pass it on to every offspring
Enzyme defecient mendelian DOs
PKU
Tay-Sachs disease
Receptor deficient mendelian DOs
familial hypercholesterolemia
Oxygen ion channels-hemoglobin mendelian DO
Sickle cell anemia
Oxygen ion channels-CFTR mendelian DO
Cystic fibrosis
Extracellular collagen mendelian DOs
Ehlers-Danlos syndromes
Cell membrane mendelian DOs
Marfan syndrome
Mendelian DOs
alterations in a single gene–>abnormal product or decreased normal product
4 main categories of Mendelian DOs
enzyme defects and their consequences
defects in membrane receptors and transport systems
alterations in structure, function, or quantity of non-enzyme proteins
mutations resulting in unusual reactions to drugs
Enzyme mutations
decreased activity or decreased amount of normal enzyme
3 major consequences of enzyme mutations
accumulation of substrate
precursor, intermediate, or alternative product that is toxic
Decreased amount of end product
failure to inactivate a tissue-damaging substrate
Example of accumulation of substrate due to enzyme mutation
Galactosemia: galactose-1-phosphate uridyltransferase deficiency
Example of decreased amount of end product due to enzyme mutation
Albinism: lack of tyrosinase–> decreased melanin
Lesch-Nyhan: increased intermediate product and their breakdown produces toxins
Example of failure to inactivate a tissue-damaging substrate due to enzyme mutation
alpha1- antitrypsin: unable to inactivate neutrophil elastase in lung–>emphysema
Examples of defects in receptors and transport systems leading to mendelian DOs
familial hypercholesterolemia: decreased synthesis of decreased function of LDL receptor–>defective transport of LDL into cells–>secondary increase in cholesterol synthesis
CF: Cl- ion transport in exocrine sweat glands, sweat ducts, lungs and pancreas defective
Sickle cell disease
alteration in structure, function, or quantity of non-enzyme proteins–> defect in structure of globin molecule
Thalassemias
alterations in structure, functions, or quantity of non-enzyme proteins
mutation in globin gene affects amount of globin chains synthesized
Examples of alterations in structure, functions, or quantity of non-enzyme proteins
collagen, spectrin, dystrophin, osteogenesis imperfecta, hereditary spherocytosis, muscular dystrophies
Enzyme deficiencies unmasked after exposure to drug
G6PD deficiency: antimalarial primaquine–>severe hemolytic anemia
Marfan syndrome inheritance and genes/chromosomes
AD
FBN1 chromosme 15Q21.1
FBN2 chromosome 5q23.31 (less common)
1 in 5,000; 70-85% familial
What is defective in Marfan’s?
extracellular glycoprotein fibrillin-1
2 fundamental mechanisms by which loss of fibrillin leads to Marfan’s
loss of structural support in microfibril rich CT
excessive activation of TGF-beta signaling
Clinical features of Marfan’s
Tall, exceptionally long extremities, long fingers and toes, increased flexibility, low lactate levels in lungs, short legs, dolicocephalic (long-headed) with frontal bossing and prominent supraorbital ridges, pectus excavatum
Ectopia lentis
seen in Marfan’s; bilateral subluxation/dislocation of the lens
Usual COD for Marfan’s
aortic dissection; can also overall have mitral valve prolapse, dilation of ascending aorta, passive dilation of the aortic valve ring and root of the aorta
Pt symptoms during aortic dissection
tearing feeling in chest or between scapula
Ehlers-Danlos syndromes (EDS)
defect in the synthesis or structure of fibrillar collagen
skin is hyperextensible, joints are hypermobile
skin is stretchable, fragile, and vulnerable to trauma
Gaping defects
seen in minor injuries in those with EDS; surgical repair or intervention is difficult due to lack of normal tensile strength
Normal COD for EDS pts
rupture of the colon and large arteries (vascular EDS)
Classic EDS internal complications
diaphragmatic hernia
Kyphoscoliosis EDS internal complications
ocular fragility with rupture of cornea and retinal detachment
Classic EDS gene defects
COL5A1, COL5A2
Vascular EDS gene defects
COL3A1
Kyphoscoliosis EDS gene defects
lysyl hydroxylase
Familial hypercholesterolemia
mutation of receptor for LDL
1 in 500 birth have a 2-3 fold increase in cholesterol
Tendinous xanthomas
deposit of cholesterol that looks yellow- seen in familial hypercholesterolemia
Risks of increased cholesterol
premature atherosclerosis, increased risk of MI
Are hetero or homozygotes more severely affected in familial hypercholesterolemia?
homozygotes: 5-6 fold increase in plasma cholesterol levels
Homozygotes in familial hypercholesterolemia risks
skin xanthomas, coronary, cerebral, and peripheral vascular atherosclerosis at early age; MI before 20 y.o.
Sign seen in eyes in homozygotes in familial hypercholesterolemia
arcus cornelius: deposit of material in cornea; usually seen in older pts but can be seen in young pts with this issue
Mutation class I familial hypercholesterolemia
no synthesis of LDL receptor
Mutation class II familial hypercholesterolemia
synthesis, but no transport of LDL receptor
Mutation class III familial hypercholesterolemia
synthesis, transport, but no binding of LDL receptor
Mutation class IV familial hypercholesterolemia
synthesis, transport, binding, but no clustering of LDL receptor
Mutation class V familial hypercholesterolemia
synthesis, transport, binding, clustering, but no recycling of LDL receptor
Lysosomal storage diseases
catabolism of the substrate of the missing enzyme remains incomplete, leading to the accumulation within the lysosomes- primary accumulation
Primary accumulation in LSD
stuffed with incompletely digested macromolecules, lysosomes become large and numerous enough to interfere with normal cell functions
Secondary accumulation in LSD
impaired lysosomal function–>impaired autophagy–>accumulation of autophagic substrates
3 general approaches to treatment of LSD
enzyme replacement therapy
substrate reduction therapy
molecular basis of enzyme deficiency
Primary storage in LSD
defective fusion of autophagosome with lysosome
defective degradation of intracellular organelles
Secondary storage in LSD
accumulation of toxic proteins
accumulation of aberrant mitochondria
Enzyme deficiency in Tay-Sachs disease
Shingolipidoses; hexosaminidase- alpha subunit
Major accumulating metabolite in Tay-Sachs disease
G M2 ganglioside
Gaucher disease enzyme deficiency
Sulfatidoses; glucocerebronsidase
Major accumulating metabolite in Gaucher disease
glucocerebroside
Niemann-Pick diseases: A and B major accumulating metabolite
Sulfatidoses; sphingomyelinase
Major accumulating metabolite in Niemann-Pick
sphingomyelin
MPS I H (Hurler) disease enzyme deficiency
Mucopolysaccharidoses (MPSs)
MPS II H (Hunter) disease enzyme deficiency
Sulfatidoses
Major accumulating metabolite in MPS I and II
dermatan sulfate, heparan sulfate
Tay-Sachs disease
GM2 Gangliosidosis: Hexosaminidase alpha-subunit deficiency
What are GM2 gangliosidoses?
a group of 3 lysosomal storage diseases caused by an inability to catabolize GM2 gangliosides
Chromosome affected in Tay-Sachs disease
mutation in the alpha-subunit locus on chromosome 15–>severe deficiency of Hexosaminidase A
Ethnic group most affected by Tay-Sachs disease
Ashkenazic Jews; carrier rate of 1 in 30
Age of onset of symptoms of Tay-Sachs disease
6 months motor and mental deterioration; obtunded, flaccidity, blindness, and dementia
Affect of Tay-Sachs disease
1-2 yo vegetative state; death by age 2-3 yo
Classic sign for Tay-Sachs disease
cherry red spot in the macula: ganglion cells of retina swollen, especially around macula